The Medical Imaging & Technology Alliance (MITA) recently commended the United States Senate for its bipartisan passage of the Trade Promotion Authority (TPA) legislation, which will eliminate unnecessary barriers to future trade agreements that affect medical imaging advancement and patient access to care.
“MITA supports TPA and efforts that will lead to the expansion of trade and investment between the United States and its trading partners, and also improve the global regulatory environment for manufacturers to ensure they remain at the forefront of technological innovation,” said Andy Dhokai, MITA’s director of federal relations. “We are optimistic that future trade agreements enabled by TPA will benefit patients around the world through expanded access to the most innovative imaging technology.”
The bill was brought to the Senate floor under the leadership of Senate Finance Committee Chairman Orrin Hatch (R-UT) and Ranking Member Ron Wyden (D-OR).
MITA is currently working with U.S. regulators and negotiators on medical imaging equipment provisions in the pending Trans Pacific Partnership (TPP) and the Trans-Atlantic Trade and Investment Partnership (TTIP) agreements. Passage of the TPA will enable the TPP and TTIP agreements to move forward. As a result, medical imaging manufacturers and other American companies will be able to hire more American workers, pay competitive wages, and help grow local economies, according to MITA.
The TPA negotiating objectives provide that negotiators reach trade agreements with regulatory transparency and accountability.
For more information, visit MITA.
